Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0064) | |||||
---|---|---|---|---|---|
DME Name | UDP-glucuronosyltransferase 1A8 (UGT1A8), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 2.4.1.17 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Brain neuroblastoma | Significant hypomethylation | |||
Interaction Name | DNMT-UGT1A8 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 1.32E-26; delta-beta: -6.05E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the UGT1A8 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A8. As a result, the interaction between DNMT and UGT1A8 can significantly affect the drug-metabolizing process of UDP-glucuronosyltransferase 1A8. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
DNA methyltransferase (DNMT) | Cerebellar liponeurocytoma | Moderate hypomethylation | |||
Interaction Name | DNMT-UGT1A8 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 2.29E-02; delta-beta: -2.48E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the UGT1A8 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A8. As a result, the interaction between DNMT and UGT1A8 can moderatly affect the drug-metabolizing process of UDP-glucuronosyltransferase 1A8. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2B90 Colorectal cancer | Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI | ||||
Transcription-factor regulation | |||||
Hepatocyte NF 1-alpha (HNF1A) | Colorectal cancer | Activation | |||
Uniprot ID | |||||
Interaction Name | HNF1A-UGT1A8 interaction | [1] | |||
Studied Cell Lines | Caco-2 cell line | ||||
Ensembl ID | |||||
Description | Hepatocyte NF 1-alpha (HNF1A) is reported to activate the transcription of UGT1A8 gene, which leads to an increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A8. As a result, the interaction between HNF1A and UGT1A8 can activate the drug-metabolizing process of UDP-glucuronosyltransferase 1A8. | ||||
Homeobox protein CDX-2 (CDX2) | Colorectal cancer | Activation | |||
Uniprot ID | |||||
Interaction Name | CDX2-UGT1A8 interaction | [1] | |||
Studied Cell Lines | Caco-2 cell line | ||||
Ensembl ID | |||||
Description | Homeobox protein CDX-2 (CDX2) is reported to activate the transcription of UGT1A8 gene, which leads to an increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A8. As a result, the interaction between CDX2 and UGT1A8 can activate the drug-metabolizing process of UDP-glucuronosyltransferase 1A8. | ||||
ICD-11: 2C90 Renal cell carcinoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Renal cell carcinoma | Significant hypermethylation | |||
Interaction Name | DNMT-UGT1A8 interaction | ||||
The Methylation Level of Disease Section Compare with the Other Disease Section | Significant hypermethylation p-value: 1.41E-02; delta-beta: 4.10E-02 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the UGT1A8 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A8. As a result, the interaction between DNMT and UGT1A8 can significantly affect the drug-metabolizing process of UDP-glucuronosyltransferase 1A8. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
DME methylation in tissue other than the diseased tissue of patients
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2D50 Brain cancer metastasis | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Esthesioneuroblastoma | Significant hypomethylation | |||
Interaction Name | DNMT-UGT1A8 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 1.38E-06; delta-beta: -3.06E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the UGT1A8 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A8. As a result, the interaction between DNMT and UGT1A8 can significantly affect the drug-metabolizing process of UDP-glucuronosyltransferase 1A8. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2F37 Endocrine gland cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Pituitary adenoma | Moderate hypomethylation | |||
Interaction Name | DNMT-UGT1A8 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 8.38E-11; delta-beta: -2.78E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the UGT1A8 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A8. As a result, the interaction between DNMT and UGT1A8 can moderatly affect the drug-metabolizing process of UDP-glucuronosyltransferase 1A8. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.